Evidence map›Paper›PMID 21169547›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2011

Bacterial lipoprotein TLR2 agonists broadly modulate endothelial function and coagulation pathways in vitro and in vivo.

Hae-Sook Shin, Fengyun Xu, Aranya Bagchi, Elizabeth Herrup, Arun Prakash, Catherine Valentine, Hrishikesh Kulkarni, Kevin Wilhelmsen, Shaw Warren, Judith Hellman

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 91 citations in OpenAlex.

  1. Angiogenesis in Inflammatory Bowel Disease.Pharmaceuticals (Basel, Switzerland) · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Low-Grade Endotoxemia and Thrombosis in COVID-19.Clinical and translational gastroenterology · 2021
    Article
  16. Review
  17. Article
  18. Bacterial products in donor airways prevent the induction of lung transplant tolerance.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2021
    Article
  19. Article
  20. The gut microbiome and thromboembolism.Thrombosis research · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Hae-Sook ShinDepartment of Anesthesia and Critical Care, Massachusetts General Hospital, Boston, MA 02114, USA.
Fengyun Xu
Aranya Bagchi
Elizabeth Herrup
Arun Prakash
Catherine Valentine
Hrishikesh Kulkarni
Kevin Wilhelmsen
Shaw Warren
Judith Hellman
University of California, San Francisco · USMassachusetts General Hospital · USHarvard University · USUniversity Medical Center · USUniversity of Massachusetts Chan Medical School · US

Funding

TLR2 in Sepsis-Induced Coagulopathy, Endothelial Leak, and Pulmonary DysfunctionR01AI058106 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HELLMAN, JUDITH · 2004 to 2010
$2.3M
BACTERIAL SURFACE PROTEINS: POTENTIAL TARGETS FOR SEPSISK08AI001722 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI HELLMAN, JUDITH · 2000 to 2004
$601k
NIAID NIH HHS K08 AI001722NIAID NIH HHS K08-AI01722NIAID NIH HHS R01 AI058106NIAID NIH HHS R01-AI 058106
6 · The paper itself

Abstract

TLR2 activation induces cellular and organ inflammation and affects lung function. Because deranged endothelial function and coagulation pathways contribute to sepsis-induced organ failure, we studied the effects of bacterial lipoprotein TLR2 agonists, including peptidoglycan-associated lipoprotein, Pam3Cys, and murein lipoprotein, on endothelial function and coagulation pathways in vitro and in vivo. TLR2 agonist treatment induced diverse human endothelial cells to produce IL-6 and IL-8 and to express E-selectin on their surface, including HUVEC, human lung microvascular endothelial cells, and human coronary artery endothelial cells. Treatment of HUVEC with TLR2 agonists caused increased monolayer permeability and had multiple coagulation effects, including increased production of plasminogen activator inhibitor-1 (PAI-1) and tissue factor, as well as decreased production of tissue plasminogen activator and tissue factor pathway inhibitor. TLR2 agonist treatment also increased HUVEC expression of TLR2 itself. Peptidoglycan-associated lipoprotein induced IL-6 production by endothelial cells from wild-type mice but not from TLR2 knockout mice, indicating TLR2 specificity. Mice were challenged with TLR2 agonists, and lungs and plasmas were assessed for markers of leukocyte trafficking and coagulopathy. Wild-type mice, but not TLR2 mice, that were challenged i.v. with TLR2 agonists had increased lung levels of myeloperoxidase and mRNAs for E-selectin, P-selectin, and MCP-1, and they had increased plasma PAI-1 and E-selectin levels. Intratracheally administered TLR2 agonist caused increased lung fibrin levels. These studies show that TLR2 activation by bacterial lipoproteins broadly affects endothelial function and coagulation pathways, suggesting that TLR2 activation contributes in multiple ways to endothelial activation, coagulopathy, and vascular leakage in sepsis.

Indexed as

AnimalsAnticoagulantsBlood CoagulationCapillary PermeabilityCell LineEndothelium, VascularEscherichia coli ProteinsHumansImmunophenotypingLipoproteinsMiceMice, Inbred C57BLMice, KnockoutPeptidoglycanSignal TransductionToll-Like Receptor 2AnticoagulantsEscherichia coli Proteinslipoprotein-associated coagulation inhibitorLipoproteinsPeptidoglycanTlr2 protein, mouseToll-Like Receptor 2

Identifiers

PMID21169547
PMCPMC3482611
OpenAlexW2162775093

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.